987
Views
50
CrossRef citations to date
0
Altmetric
Poison Centre Research

Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014–2017

ORCID Icon, , , &
Pages 282-286 | Received 02 Jul 2018, Accepted 08 Aug 2018, Published online: 15 Nov 2018

References

  • Schifano F, Orsolini L, Duccio Papanti G, et al. Novel psychoactive substances of interest for psychiatry. World Psych. 2015;14:15–26.
  • Corazza O, Valeriani G, Bersani FS, et al. “Spice,” “Kryptonite,” “Black Mamba”: An Overview of Brand Names and Marketing Strategies of Novel Psychoactive Substances on the Web. J of Psycho Drug. 2014;46:287–294.
  • Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol. 2012;8:33–42.
  • Tait RJ, Caldicott D, Mountain D, et al. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol. 2016;54:1–13.
  • Adams AJ, Banister SD, Irizarry L, et al. “Zombie”; Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York”. N Engl J Med. 2017;376:235–242.
  • Moosmann B, King LA, Auwärter V. Designer benzodiazepines: a new challenge. World Psych. 2015;14:248
  • Logan BK, Mohr AL, Friscia M, et al. Reports of adverse events associated with use of novel psychoactive substances, 2013–2016: a review. J Anal Toxicol. 2017;41:573–610.
  • Huppertz LM, Bisel P, Westphal F, et al. Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites. Forensic Toxicol. 2015;33:388–395.
  • Høiseth G, Tuv SS, Karinen R. Blood concentrations of new designer benzodiazepines in forensic cases. Forensic Sci Int. 2016;268:35–38.
  • O'Connell CW, Sadler CA, Tolia VM, et al. Overdose of etizolam: the abuse and rise of a benzodiazepine analog. Ann Emerg Med. 2015;65:465–466.
  • Graddy R, Buresh ME, Rastegar DA. New and emerging illicit psychoactive substances. Med Clin North Am. 2018;102:697–714.
  • Łukasik-Głębocka M, Sommerfeld K, Teżyk A, et al. Flubromazolam-A new life-threatening designer benzodiazepine . Clin Toxicol. 2016;54:66–68.
  • Nakamae T, Shinozuka T, Sasaki C, et al. Case report: Etizolam and its major metabolites in two unnatural death cases. Foren Sci Int. 2008;182:e1–e6.
  • Arens AM, van Wijk XM, Vo KT, et al. Adverse effects from counterfeit alprazolam tablets. JAMA Intern Med. 2016;176:1554–1555.
  • Gummin DD, Mowry JB, Spyker DA, et al. 2016 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th Annual Report. Clinical Toxicology. 2017;55:1072–1254.
  • U.S. Census Bureau PD. Annual Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2016 (NST-EST2016-01). 2016.
  • Penninga EI, Graudal N, Ladekarl MB, et al. Adverse events associated with flumazenil treatment for the management of suspected benzodiazepine Intoxication-A Systematic Review with Meta-Analyses of Randomised Trials. Basic Clin Pharmacol Toxicol. 2016;118:37–44.
  • Veiraiah A. This meta-analysis does not reflect current practice and overestimates SAEs. Basic Clin Pharmacol Toxicol. 2015;117:363.
  • Pettersson Bergstrand M, Helander A, Hansson T, et al. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays. Drug Test Anal. 2017;9:640–645.
  • Bergstrand MP, Helander A, Beck O. Development and application of a multi-component LC–MS/MS method for determination of designer benzodiazepines in urine. J Chromat B. 2016;1035:104–110.
  • Tomková J, Švidrnoch M, Maier V, et al. Analysis of selected designer benzodiazepines by ultra high performance liquid chromatography with high‐resolution time‐of‐flight mass spectrometry and the estimation of their partition coefficients by micellar electrokinetic chromatography. J Sep Sci. 2017;40:2037–2044.
  • Pettersson Bergstrand M, Meyer MR, Beck O, et al. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography–high resolution mass spectrometry. Drug Test Anal. 2018;10:496–506.
  • Stephenson JB, Golz DE, Brasher MJ. Phenazepam and its effects on driving. J Anal Toxicol. 2013;37:25–29.
  • Schneider K, Leusby T, Lo B, et al. editors. An overdose death involving designer benzodiazepine flubromazolam. Society of Forensic Toxicologists 2016 Annual Meeting; 2016 Oct; Dallas, TX.
  • Friscia M, Jolliff H, Logan B, editors. Toxicological confirmation of intoxications involving the designer benzodiazepine clonazolam. Society of Forensic Toxicologists 2016 Annual Meeting; 2016 Oct; Dallas, TX.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.